Adrenal disease

Long-term follow-up of autoimmune polyendocrine syndrome type 1 in Norway

J Clin Endocrinol MetabPublished Registry-based longitudinal cohort study

Authors' conclusion

APS-1 should be considered in patients diagnosed with PAI before age 20, and AIRE sequencing is recommended for diagnostic confirmation. The presence of IFN-ω autoantibodies, a proinflammatory cytokine profile, and increased soluble IFN receptor levels further support the role of dysregulated interferon responses in APS-1 pathogenesis.

Study context

Population
All known Norwegian patients with APS-1, Norwegian Registry of Organ-specific Autoimmune Diseases
Participants
71 patients
Exposure
Classical vs nonclassical APS-1
  • Classicaln = 49
  • Nonclassicaln = 22
Outcome
Most frequent clinical manifestations
Methodological detailspopulation-based, long-term follow-up (1996-2025)
  • Population-based
  • Long-term follow-up (1996-2025)

Main finding

As reported in the abstract

  • Classical APS-1: chronic mucocutaneous candidiasis, enamel hypoplasia and primary adrenal insufficiency (PAI) most frequent
  • Nonclassical APS-1: vitiligo, hypothyroidism and PAI most common

Observational data: associations, not effects.

Further findings

Cytokine profile

Broad proinflammatory cytokine signature in classical APS-1, with increased soluble interferon (IFN)-α/β receptor levels

Original publication

Long-term follow-up of autoimmune polyendocrine syndrome type 1 in Norway. J Clin Endocrinol Metab. Published 12 February 2026. doi:10.1210/clinem/dgag060

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.